Date: 21/04/2020

Galenika donates EUR 400,000 to combat COVID-19

Galenika has produced and donates 372,000 tablets of the drug Hydroxychloroquine Sulfate. The value of the manufactured medicines is EUR 400,000.

Galenika has produced and placed 372,000 tablets of the drug Hydroxychloroquine Sulfate on the disposal of the Government of the Republic of Serbia. The value of the manufactured medicines, which Galenika will donate to the health system of the Republic of Serbia, is EUR 400.000. Complete quantities of the medicine will be handed over to the Republic Health Insurance Fund.

“We share the concerns of the citizens of the Republic of Serbia in this difficult time. We are working hard to ensure continuity of supply and to provide security for patients and consumers by providing sufficient quantities of our products. Hydroxychloroquine production and donation is our contribution to the common struggle of Serbian citizens and an expression of our desire to support the efforts of the Serbian health system as a socially responsible company. Personally, I am glad that our parent company EMS from Brazil recognized the need and supported our local team in Serbia and our desire to help Serbia. We are all extremely proud of our Galenika employees who have worked hard and with great dedication and Easter to produce Hydroxychloroquine, ”said Ricardo Vian Marques, General Manager of Galenika a.d Belgrade.